Literature DB >> 10675551

Expression of fatty acid-CoA ligase 4 during development and in brain.

Y Cao1, K J Murphy, T M McIntyre, G A Zimmerman, S M Prescott.   

Abstract

Fatty acid utilization is initiated by fatty acid-CoA ligase, which converts free fatty acids into fatty acyl-CoA esters. We have cloned previously the human long-chain fatty acid-CoA ligase 4 (FACL4), which is a central enzyme in controlling the free arachidonic acid level in cells and thereby regulating eicosanoid production. We report here the expression of this gene in tissues, particularly in different parts of the brain. We found that FACL4 encoded a 75 kDa enzyme and that there was a modified translation product expressed in the brain. FACL4 was expressed in early stages of development with a significant amount of FACL4 mRNA detected in an E7 mouse embryo. In addition, FACL4 was highly expressed in both adult and newborn mouse brain especially in the granule cells of the dentate gyrus and the pyramidal cell layer of CA1 in hippocampus, and the granular cell layer and Purkinje cells of the cerebellum.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10675551     DOI: 10.1016/s0014-5793(00)01159-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

1.  Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: relevance to valproate's efficacy against bipolar disorder.

Authors:  Jakob A Shimshoni; Mireille Basselin; Lei O Li; Rosalind A Coleman; Stanley I Rapoport; Hiren R Modi
Journal:  Biochim Biophys Acta       Date:  2010-12-22

2.  PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.

Authors:  Chin Fung Kelvin Kan; Amar Bahadur Singh; Bin Dong; Vikram Ravindra Shende; Jingwen Liu
Journal:  Biochim Biophys Acta       Date:  2015-01-31

3.  Valnoctamide, a non-teratogenic amide derivative of valproic acid, inhibits arachidonic acid activation in vitro by recombinant acyl-CoA synthetase-4.

Authors:  Hiren R Modi; Mireille Basselin; Stanley I Rapoport
Journal:  Bipolar Disord       Date:  2014-07-08       Impact factor: 6.744

4.  Tyrosine phosphatase SHP2 regulates the expression of acyl-CoA synthetase ACSL4.

Authors:  Mariana Cooke; Ulises Orlando; Paula Maloberti; Ernesto J Podestá; Fabiana Cornejo Maciel
Journal:  J Lipid Res       Date:  2011-09-08       Impact factor: 5.922

5.  Intracellular unesterified arachidonic acid signals apoptosis.

Authors:  Y Cao; A T Pearman; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

6.  Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.

Authors:  Paula M Maloberti; Alejandra B Duarte; Ulises D Orlando; María E Pasqualini; Angela R Solano; Carlos López-Otín; Ernesto J Podestá
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

7.  Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorder.

Authors:  Hiren R Modi; Mireille Basselin; Ameer Y Taha; Lei O Li; Rosalind A Coleman; Meir Bialer; Stanley I Rapoport
Journal:  Biochim Biophys Acta       Date:  2013-01-23

8.  Integrin alphaDbeta2 is dynamically expressed by inflamed macrophages and alters the natural history of lethal systemic infections.

Authors:  Yasunari Miyazaki; Michaeline Bunting; Diana M Stafforini; Estelle S Harris; Thomas M McIntyre; Stephen M Prescott; Valber S Frutuoso; Fabio C Amendoeira; Danielle de Oliveira Nascimento; Adriana Vieira-de-Abreu; Andrew S Weyrich; Hugo C Castro-Faria-Neto; Guy A Zimmerman
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

Review 9.  Acyl-CoA synthesis, lipid metabolism and lipotoxicity.

Authors:  Lei O Li; Eric L Klett; Rosalind A Coleman
Journal:  Biochim Biophys Acta       Date:  2009-10-08

10.  Targeting the lipid metabolic axis ACSL/SCD in colorectal cancer progression by therapeutic miRNAs: miR-19b-1 role.

Authors:  Silvia Cruz-Gil; Ruth Sanchez-Martinez; Marta Gomez de Cedron; Roberto Martin-Hernandez; Teodoro Vargas; Susana Molina; Jesús Herranz; Alberto Davalos; Guillermo Reglero; Ana Ramirez de Molina
Journal:  J Lipid Res       Date:  2017-10-26       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.